D-1813-2015 Class III Terminated
FDA drug recall D-1813-2015 was initiated by EMD Serono, Inc. on Sep 10, 2015 and is designated Class III. Reason for recall: Chemical Contamination: impurity failure due to chemical contamination of the active ingredient. The recall status is terminated (terminated Feb 13, 2017). Affected quantity: 37,078 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 23, 2015
- Initiation Date
- Sep 10, 2015
- Termination Date
- Feb 13, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 37,078 cartons
Product description
ClomiPHENE CITRATE Tablets, USP, 50 mg, 10-count (2 foil sealed plastic trays of 5 tablets each) per carton, Rx only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD., Jerusalem, 91010, Israel; Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960; NDC 0093-0041-03, UPC 3 0093-0041-03 7.
Reason for recall
Chemical Contamination: impurity failure due to chemical contamination of the active ingredient.
Distribution pattern
Nationwide
Code information
Lot #: 233169, Exp 02/16
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1813-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026